CONFIDENTIAL – Contains proprietary information.
Not intended for external distribution.
5
What We Accomplished in FY25
Reviewed 535
new study leads
Enrolled 3,035
patients
(treatment trials)
Activated 341
unique studies
*Metrics as of March 19, 2025 –
comparing from FY24
27%
Increase
5%
Increase
9%
Increase
7%
Increase
Activated 845
engagements
